ea0059p205 | Thyroid | SFEBES2018
Seejore Khyatisha
, Nawaz Fozia
, Kelleher Katherine
, Kyaw-Tun Julie
, Lynch Julie
, Murray Robert D
Background: Antithyroid drugs (ATDs) are preferred as a first-line treatment for Graves disease (GD). However, around 5060% of patients relapse following treatment withdrawal. Radioactive iodine (RAI) or thyroidectomy is recommended for these patients, however, repeat ATD therapy is a further option, dependent upon patient choice. The long-term efficacy of ATD in relapsed GD has not been robustly established.Methods: We conducted a retrospect...